Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357913

Medchemexpress LLC Silmitasertib sodium salt | 1309357-15-0 | 99.9% | C19H11ClN3NaO2 | 100 MG
SDP

Catalog No. 5000357913
Encompass_Preferred

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor.

  • Causes cell-cycle arrest and selectively induces apoptosis in cancer cells by attenuating PI3K/Akt signaling.
  • Antiproliferative activity correlates with CK2α catalytic subunit expression.
  • Prevents leukemic cells from engaging UPR during PS-341 treatment, reducing BIP/Grp78 expression.
  • Induces cytotoxicity and apoptosis, exerting anti-proliferative effects in hematological tumors.
  • Demonstrates robust antitumor activity and reduces phospho-p21 (T145) in murine xenograft models.

Catalog No. 50-003-57913 Supplier Medchemexpress LLC Supplier No. HY50855B100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor.

  • Causes cell-cycle arrest and selectively induces apoptosis in cancer cells by attenuating PI3K/Akt signaling.
  • Antiproliferative activity correlates with CK2α catalytic subunit expression.
  • Prevents leukemic cells from engaging UPR during PS-341 treatment, reducing BIP/Grp78 expression.
  • Induces cytotoxicity and apoptosis, exerting anti-proliferative effects in hematological tumors.
  • Demonstrates robust antitumor activity and reduces phospho-p21 (T145) in murine xenograft models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.